Idexx Laboratories (IDXX) closed at $670.71 on November 5, 2026, down 4.0% from the previous close, on volume of 817,314 shares (30-day average 601,594).
Data as of November 5, 2026.
5-Nov-2026
BofA adds TSLA, AVGO, IBM, others to its Global Defenders list
Seeking Alpha News (Thu, 5-Nov 10:17 AM ET)
Analysts’ Top Healthcare Picks: Viridian Therapeutics (VRDN), Idexx Laboratories (IDXX)
TipRanks (Tue, 3-Nov 9:30 PM ET)
TipRanks (Mon, 2-Nov 9:41 PM ET)
TipRanks (Mon, 2-Nov 9:00 PM ET)
IDEXX Laboratories Earnings Call Signals Strong Growth
TipRanks (Mon, 2-Nov 7:04 PM ET)
Midday Pulse: S&P 500 top intraday gainers
Seeking Alpha News (Mon, 2-Nov 12:02 PM ET)
S&P 500 gainers: Today’s top performers ranked by Quant
Seeking Alpha News (Mon, 2-Nov 11:57 AM ET)
Market Chameleon (Mon, 2-Nov 6:02 AM ET)
Biggest stock movers Monday: KOS, INO, LITE, AMZN, and more
Seeking Alpha News (Mon, 2-Nov 10:09 AM ET)
IDEXX Laboratories beats top-line and bottom-line estimates; updates FY26 outlook
Seeking Alpha News (Mon, 2-Nov 6:36 AM ET)
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Idexx Laboratories trades on the NASDAQ stock market under the symbol IDXX.
As of November 5, 2026, IDXX stock price declined to $670.71 with 817,314 million shares trading.
IDXX has a beta of 0.49, meaning it tends to be less sensitive to market movements. IDXX has a correlation of 0.04 to the broad based SPY ETF.
IDXX has a market cap of $52.84 billion. This is considered a Large Cap stock.
Last quarter Idexx Laboratories reported $1 billion in Revenue and $4.01 earnings per share. This beat revenue expectation by $22 million and exceeded earnings estimates by $.30.
In the last 3 years, IDXX traded as high as $769.98 and as low as $356.14.
The top ETF exchange traded funds that IDXX belongs to (by Net Assets): VTI, QQQ, VOO, VO, IVV.
IDXX has underperformed the market in the last year with a return of -7.1%, while SPY returned +9.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in IDXX shares. However, IDXX has outperformed the market in the last 3 month and 2 week periods, returning +14.0% and +21.2%, while SPY returned -4.7% and -5.2%, respectively. This indicates IDXX has been having a stronger performance recently.
IDXX support price is $686.67 and resistance is $710.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IDXX shares will trade within this expected range on the day.